Olympus Pharma Machines Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.11 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 0.50 M
About Olympus Pharma Machines
Olympus Pharma Machines Private Limited (OPMPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 2005 and has a history of 19 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Industrial Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹0.50 M.
Kaushik Bose and Samir Dey serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U29297MH2005PTC157381
-
Company No.
157381
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Nov 2005
-
Date of AGM
30 Sep 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Olympus Pharma Machines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushik Bose
|
Director | 06-Jul-2006 | Current |
|
Samir Dey
|
Director | 18-Nov-2005 | Current |
Financial Performance of Olympus Pharma Machines.
Enhance accessibility to Olympus Pharma Machines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olympus Pharma Machines?
Unlock access to Olympus Pharma Machines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- The Bharat Co-Operative Bank (Mumbai) Limited : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2007 | The Bharat Co-Operative Bank (Mumbai) Limited | ₹0.50 M | Open |
How Many Employees Work at Olympus Pharma Machines?
Unlock and access historical data on people associated with Olympus Pharma Machines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olympus Pharma Machines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olympus Pharma Machines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
